Evidence map›Paper›PMID 28087985›Full record

ArticleJournal of gastroenterology and hepatology2017

Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.

Gail A Cresci, Bryan Glueck, Megan R McMullen, Wei Xin, Daniella Allende, Laura E Nagy

Open access · greenAbstract read
In one paragraph

Article in Journal of gastroenterology and hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Frontiers in microbiology · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Impact of High-Temperature Feeds on Gut Microbiota and MAFLD.Journal of microbiology and biotechnology · 2024
    Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gail A CresciDepartment of Pathobiology, Cleveland Clinic, Cleveland, Ohio, USA.
Bryan GlueckDepartment of Pathobiology, Cleveland Clinic, Cleveland, Ohio, USA.
Megan R McMullenDepartment of Pathobiology, Cleveland Clinic, Cleveland, Ohio, USA.
Wei XinDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Daniella AllendeDepartment of Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
Laura E NagyDepartment of Pathobiology, Cleveland Clinic, Cleveland, Ohio, USA.
Cleveland Clinic · USCase Western Reserve University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Project Two - Exercise Training Decreases Alcohol Drinking by an FGF21-Dependent MechanismP50AA024333 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI Thomas M McIntyre · 2016 to 2026
$19.6M
The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Theresa Torres Pizarro · 2015 to 2026
$15.6M
Pilot ProjectP20AA017837 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI GHOLAM, PIERRE MICHEL · 2009 to 2013
$2.2M
Novel therapeutics for alcoholic hepatitis - Cleveland Translational ComponentU01AA021890 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI NAGY, LAURA E. · 2012 to 2017
$1.6M
Targeting ethanol-induced gut dysbiosis with synbiotics to treat alcoholic liverR00AA023266 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI CRESCI, GAIL ANN · 2017 to 2019
$747k
Targeting ethanol-induced gut dysbiosis with synbiotics to treat alcoholic liverK99AA023266 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI CRESCI, GAIL ANN · 2015 to 2016
$271k
Role of Butyrate in the Gut-Liver Interaction of Ethanol Induced Liver InjuryF32AA021044 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI CRESCI, GAIL ANN · 2011 to 2013
$155k
NCATS NIH HHS UL1 TR000439NCRR NIH HHS UL1 RR024989NIAAA NIH HHS F32 AA021044NIAAA NIH HHS K99 AA023266NIAAA NIH HHS P20 AA017837NIAAA NIH HHS P50 AA024333NIAAA NIH HHS R00 AA023266NIAAA NIH HHS U01 AA021890NIDDK NIH HHS P30 DK097948
6 · The paper itself

Abstract

BACKGROUND AND

aimImpaired gut-liver axis is a potential factor contributing to alcoholic liver disease. Ethanol depletes intestinal integrity and causes gut dysbiosis. Butyrate, a fermentation byproduct of gut microbiota, is altered negatively following chronic ethanol exposure. This study aimed to determine whether prophylactic tributyrin could protect the intestinal barrier and liver in mice during combined chronic-binge ethanol exposure.

methodsC57BL/6J mice exposed to 5% v/v ethanol-containing diet for 10 days received a single ethanol gavage (5 g/kg) 9 h before euthanasia. Control mice were isocalorically pair-fed maltose dextrin for ethanol. Diets were supplemented (5 mM) with tributyrin or glycerol. Intestine and liver disease activity was assessed histologically. Protein and mRNA expression of tight junction (TJ) proteins, toll-like receptors, and tumor necrosis factor-alpha were assessed. Caco-2 monolayers with or without ethanol exposure and/or sodium butyrate were used to test butyrate's direct effects on intestinal integrity.

resultsChronic-binge ethanol feeding impaired intestinal TJ protein co-localization staining; however, tributyrin co-treatment mitigated these effects. Ethanol depleted TJ and transepithelial electrical resistance in Caco-2 monolayers, but butyrate co-treatment reduced these effects. Hepatic toll-like receptor mRNA expression and tumor necrosis factor-alpha protein expression was induced by ethanol; however, the response was significantly dampened in mice co-treated with tributyrin. Tributyrin altered localization of both neutrophils and single hepatocyte death: Leukocytes and apoptotic hepatocytes localized predominantly around the portal tract in ethanol-only treated mice, whereas localization predominated around the central vein in ethanol-tributyrin mice.

conclusionsProphylactic tributyrin supplementation mitigated effects of combined chronic-binge ethanol exposure on disruption of intestinal TJ localization and intestinal permeability and liver injury.

Indexed as

AnimalsCell Membrane PermeabilityChemical and Drug Induced Liver Injury, ChronicEthanolFemaleIntestinal MucosaLiver Diseases, AlcoholicMice, Inbred C57BLTight Junction ProteinsTriglyceridesEthanolTight Junction ProteinstributyrinTriglyceridesalcoholic liver diseasechronic-binge ethanolgut permeabilitytight junction proteinstributyrin

Identifiers

PMID28087985
PMCPMC5511097
OpenAlexW2572192644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.